IT·Science
Technology
[Analysis of K-Bio M&A] Big Pharma on a Biotech Shopping Spree in China… Potential Targets for Major K-Bio M&A Deals (Part 2)
As global Big Pharma companies embark on large-scale mergers and acquisitions (M&A) to overcome the patent cliff and growth limitations, there are increasing instances of Chinese biotech companies bei…
Technology
[Analysis of K-Bio M&A] Even Big Pharma Companies Are Merging… But K-Bio Is Left Out of Global M&A (Part 1)
A mega-pharmaceutical company with a market capitalization of approximately $400 billion (about 570 trillion won) was on the verge of being formed. This came as AstraZeneca, a leading global pharmaceu…
Technology
Lundbeck Explores Other Indications for 'APB-A1'… "A Negative Sign, Even If Development Isn't Halted"
AprilBio Co.,Ltd.(397030)has decided to explore other indications for “APB-A1” (Lu AG22515), a technology it licensed to Lundbeck, after the compound failed to demonstrate the expected clinical effica…
Mobile
Even Older Phones Are Selling Well… 63% of Used Phones Are “3 Years or Older Since Release”
LG Uplus(032640) MediaLog, a subsidiary of Samsung Electronics, announced on the 19th that among used phones sold on its platform “Cello” from January through July of this year, devices released three…
Internet
[Exclusive] Hong Min-taek Received 2.8 Billion Won in Compensation Upon Leaving Kakao… The Outcome of the “KakaoTalk Redesign Controversy”
Hong Min-taek, the former Chief Product Officer (CPO) whom Kakao(035720)recruited in February 2025 to infuse the company with “innovation DNA,” has left the company after approximately one year and th…
Internet
[Op-Ed] Three-Way Race for the Top Spot: The Benchmark Leader Has Fallen
The results of the second evaluation for the “Independent Artificial Intelligence (AI) Foundation Model” (DOKPAMO) development project, announced by the Ministry of Science and ICT on the 18th, are cl…
Technology
U.S. FDA Approves Anticancer Virus for the First Time in 11 Years… Positive News for SillaJen, Inc.’s ‘SJ-600’
With the U.S. Food and Drug Administration (FDA) approving a new oncolytic virus therapy for the first time in about 11 years, attention in South Korea is turning to SillaJen, Inc.(215600), which is d…
Technology
LGCHEM,LTD Begins Preclinical Trials for ‘GNV205,’ an Immunotherapy Drug Based on Genube Technology
#
LGCHEM,LTD is set to begin preclinical research on “GNV205,” an antibody-cytokine fusion candidate acquired from the domestic biotech firm GenuV. The company plans to develop it as a next-gen…
Telecommunications & Broadcasting
KTCorporation Launches Product Featuring Its Proprietary LLM 'Mideum K 2.5 Pro' on a Domestically Produced NPU
KT (KTCorporation(030200)) announced on the 19th that it has launched a Sovereign AI Appliance (a turnkey device combining hardware and software) for enterprises that integrates domestically developed…
Technology
Pangen Biotech Inc. Develops 7 Biosimilars… Expanding Product Portfolio Following EPO
# Pangen Biotech Inc.(222110), a biopharmaceutical company affiliated with Huons Co., Ltd., announced on the 19th that it is expanding its biosimilar product portfolio and contract development and man…